Exagamglogene Autotemcel
CAS 2872190-45-3Biologic
Overview
Exagamglogene autotemcel is a gene therapy product designed to treat beta-thalassemia. It works by modifying a patient's own hematopoietic stem cells to produce functional beta-globin, thereby alleviating the symptoms of thalassemia major.
Therapeutic areas
HematologyGenetic Disorders
Verified Supplier Partner
Do you supply Exagamglogene Autotemcel? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.